10 20 30 40 50 60 70 80 1MGX - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER COAGULATION FACTOR 21-JUN-95 1MGX
TITLE COAGULATION FACTOR, MG(II), NMR, 7 STRUCTURES (BACKBONE TITLE 2 ATOMS ONLY)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR IX; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: THE GLA AND AROMATIC AMINO ACID STACK DOMAINS COMPND 5 FROM RESIDUES 1 - 47; COMPND 6 EC: 3.4.21.22; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606
KEYWDS COAGULATION FACTOR, SIGNAL, PLASMA
EXPDTA SOLUTION NMR
NUMMDL 7
AUTHOR S.J.FREEDMAN,B.C.FURIE,B.FURIE,J.D.BALEJA
REVDAT 2 24-FEB-09 1MGX 1 VERSN REVDAT 1 08-NOV-96 1MGX 0
JRNL AUTH S.J.FREEDMAN,M.D.BLOSTEIN,J.D.BALEJA,M.JACOBS, JRNL AUTH 2 B.C.FURIE,B.FURIE JRNL TITL IDENTIFICATION OF THE PHOSPHOLIPID BINDING SITE IN JRNL TITL 2 THE VITAMIN K-DEPENDENT BLOOD COAGULATION PROTEIN JRNL TITL 3 FACTOR IX. JRNL REF J.BIOL.CHEM. V. 271 16227 1996 JRNL REFN ISSN 0021-9258 JRNL PMID 8663165 JRNL DOI 10.1074/JBC.271.27.16227
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DGII REMARK 3 AUTHORS : HAVEL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1MGX COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 7 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(RES=RESIDUE NAME; REMARK 470 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 470 MODELS 1-7 REMARK 470 RES CSSEQI ATOMS REMARK 470 TYR A 1 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 1 OH REMARK 470 ASN A 2 CB CG OD1 ND2 REMARK 470 SER A 3 CB OG REMARK 470 LYS A 5 CB CG CD CE NZ REMARK 470 LEU A 6 CB CG CD1 CD2 REMARK 470 CGU A 7 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 7 OE22 REMARK 470 CGU A 8 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 8 OE22 REMARK 470 PHE A 9 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL A 10 CB CG1 CG2 REMARK 470 GLN A 11 CB CG CD OE1 NE2 REMARK 470 ASN A 13 CB CG OD1 ND2 REMARK 470 LEU A 14 CB CG CD1 CD2 REMARK 470 CGU A 15 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 15 OE22 REMARK 470 ARG A 16 CB CG CD NE CZ NH1 NH2 REMARK 470 CGU A 17 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 17 OE22 REMARK 470 CYS A 18 CB SG REMARK 470 MET A 19 CB CG SD CE REMARK 470 CGU A 20 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 20 OE22 REMARK 470 CGU A 21 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 21 OE22 REMARK 470 LYS A 22 CB CG CD CE NZ REMARK 470 CYS A 23 CB SG REMARK 470 SER A 24 CB OG REMARK 470 PHE A 25 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 CGU A 26 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 26 OE22 REMARK 470 CGU A 27 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 27 OE22 REMARK 470 ALA A 28 CB REMARK 470 ARG A 29 CB CG CD NE CZ NH1 NH2 REMARK 470 CGU A 30 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 30 OE22 REMARK 470 VAL A 31 CB CG1 CG2 REMARK 470 PHE A 32 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 CGU A 33 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 33 OE22 REMARK 470 ASN A 34 CB CG OD1 ND2 REMARK 470 THR A 35 CB OG1 CG2 REMARK 470 CGU A 36 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 36 OE22 REMARK 470 ARG A 37 CB CG CD NE CZ NH1 NH2 REMARK 470 THR A 38 CB OG1 CG2 REMARK 470 THR A 39 CB OG1 CG2 REMARK 470 CGU A 40 CB CG CD1 CD2 OE11 OE12 OE21 REMARK 470 CGU A 40 OE22 REMARK 470 PHE A 41 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP A 42 CB CG CD1 CD2 NE1 CE2 CE3 REMARK 470 TRP A 42 CZ2 CZ3 CH2 REMARK 470 LYS A 43 CB CG CD CE NZ REMARK 470 GLN A 44 CB CG CD OE1 NE2 REMARK 470 TYR A 45 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 45 OH REMARK 470 VAL A 46 CB CG1 CG2 REMARK 470 ASP A 47 CB CG OD1 OD2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A 3 -79.69 -133.50 REMARK 500 1 VAL A 10 -153.61 -125.04 REMARK 500 1 GLN A 11 132.71 177.84 REMARK 500 1 CYS A 23 -99.61 -133.76 REMARK 500 1 SER A 24 148.18 -177.93 REMARK 500 1 THR A 38 -46.29 146.81 REMARK 500 1 VAL A 46 -146.09 -103.58 REMARK 500 2 ASN A 2 171.85 -50.72 REMARK 500 2 GLN A 11 -164.76 -70.98 REMARK 500 2 CYS A 23 14.78 -145.63 REMARK 500 2 SER A 24 -165.51 49.90 REMARK 500 2 VAL A 46 -145.54 -96.51 REMARK 500 3 ASN A 2 122.65 69.40 REMARK 500 3 SER A 3 -90.99 42.04 REMARK 500 3 LYS A 5 43.70 -142.36 REMARK 500 3 VAL A 10 -142.81 -96.81 REMARK 500 3 CYS A 23 -152.23 -110.55 REMARK 500 4 SER A 3 19.48 51.03 REMARK 500 4 LYS A 5 78.55 71.64 REMARK 500 4 VAL A 10 -143.38 -116.65 REMARK 500 4 GLN A 11 -138.42 -88.23 REMARK 500 4 ASN A 13 -137.10 -74.22 REMARK 500 4 CYS A 23 -144.22 -137.81 REMARK 500 4 THR A 38 -47.23 136.10 REMARK 500 5 ASN A 2 145.44 76.61 REMARK 500 5 LYS A 5 40.45 -96.23 REMARK 500 5 GLN A 11 -161.63 -61.44 REMARK 500 5 CYS A 23 -140.96 -133.22 REMARK 500 5 VAL A 46 -138.84 -129.21 REMARK 500 6 GLN A 11 99.23 76.94 REMARK 500 6 ASN A 13 -139.15 -84.40 REMARK 500 6 CYS A 23 -150.63 -131.56 REMARK 500 6 VAL A 46 -145.51 -138.98 REMARK 500 7 ASN A 2 177.88 57.35 REMARK 500 7 SER A 3 -75.61 -12.80 REMARK 500 7 VAL A 10 -98.42 -63.58 REMARK 500 7 GLN A 11 13.38 133.12 REMARK 500 7 CYS A 23 -105.96 -125.54 REMARK 500 7 VAL A 46 156.24 -34.70 REMARK 500 REMARK 500 REMARK: NULL
DBREF 1MGX A 1 47 UNP P00740 FA9_HUMAN 47 93
SEQADV 1MGX CGU A 7 UNP P00740 GLU 53 CONFLICT SEQADV 1MGX CGU A 8 UNP P00740 GLU 54 CONFLICT SEQADV 1MGX CGU A 15 UNP P00740 GLU 61 CONFLICT SEQADV 1MGX CGU A 17 UNP P00740 GLU 63 CONFLICT SEQADV 1MGX CGU A 20 UNP P00740 GLU 66 CONFLICT SEQADV 1MGX CGU A 21 UNP P00740 GLU 67 CONFLICT SEQADV 1MGX CGU A 26 UNP P00740 GLU 72 CONFLICT SEQADV 1MGX CGU A 27 UNP P00740 GLU 73 CONFLICT SEQADV 1MGX CGU A 30 UNP P00740 GLU 76 CONFLICT SEQADV 1MGX CGU A 33 UNP P00740 GLU 79 CONFLICT SEQADV 1MGX CGU A 36 UNP P00740 GLU 82 CONFLICT SEQADV 1MGX CGU A 40 UNP P00740 GLU 86 CONFLICT
SEQRES 1 A 47 TYR ASN SER GLY LYS LEU CGU CGU PHE VAL GLN GLY ASN SEQRES 2 A 47 LEU CGU ARG CGU CYS MET CGU CGU LYS CYS SER PHE CGU SEQRES 3 A 47 CGU ALA ARG CGU VAL PHE CGU ASN THR CGU ARG THR THR SEQRES 4 A 47 CGU PHE TRP LYS GLN TYR VAL ASP
MODRES 1MGX CGU A 7 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 8 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 15 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 17 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 20 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 21 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 26 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 27 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 30 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 33 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 36 GLU GAMMA-CARBOXY-GLUTAMIC ACID MODRES 1MGX CGU A 40 GLU GAMMA-CARBOXY-GLUTAMIC ACID
HET CGU A 7 4 HET CGU A 8 4 HET CGU A 15 4 HET CGU A 17 4 HET CGU A 20 4 HET CGU A 21 4 HET CGU A 26 4 HET CGU A 27 4 HET CGU A 30 4 HET CGU A 33 4 HET CGU A 36 4 HET CGU A 40 4
HETNAM CGU GAMMA-CARBOXY-GLUTAMIC ACID
FORMUL 1 CGU 12(C6 H9 N O6)
HELIX 1 1 LEU A 14 ARG A 16 1 3 HELIX 2 2 PHE A 25 PHE A 32 1 8 HELIX 3 3 THR A 35 TYR A 45 1 11
LINK N CGU A 7 C LEU A 6 1555 1555 1.32 LINK C CGU A 7 N CGU A 8 1555 1555 1.32 LINK C CGU A 8 N PHE A 9 1555 1555 1.32 LINK N CGU A 15 C LEU A 14 1555 1555 1.32 LINK C CGU A 15 N ARG A 16 1555 1555 1.32 LINK N CGU A 17 C ARG A 16 1555 1555 1.32 LINK C CGU A 17 N CYS A 18 1555 1555 1.32 LINK N CGU A 20 C MET A 19 1555 1555 1.32 LINK C CGU A 20 N CGU A 21 1555 1555 1.32 LINK C CGU A 21 N LYS A 22 1555 1555 1.32 LINK N CGU A 26 C PHE A 25 1555 1555 1.32 LINK C CGU A 26 N CGU A 27 1555 1555 1.32 LINK C CGU A 27 N ALA A 28 1555 1555 1.32 LINK N CGU A 30 C ARG A 29 1555 1555 1.32 LINK C CGU A 30 N VAL A 31 1555 1555 1.32 LINK N CGU A 33 C PHE A 32 1555 1555 1.32 LINK C CGU A 33 N ASN A 34 1555 1555 1.32 LINK N CGU A 36 C THR A 35 1555 1555 1.32 LINK C CGU A 36 N ARG A 37 1555 1555 1.32 LINK N CGU A 40 C THR A 39 1555 1555 1.32 LINK C CGU A 40 N PHE A 41 1555 1555 1.32
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000